Editorial: Advances in Parkinson's Disease Research: Exploring Biomarkers and Therapeutic Strategies for Halting Disease Progression

Editorial: Advances in Parkinson's Disease Research: Exploring Biomarkers and Therapeutic Strategies for Halting Disease Progression

Saved in:

Bibliographic Details
Main Authors:	Anastasia Bougea, Yildiz Degirmenci
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Series:	Frontiers in Aging Neuroscience
Subjects:	biomarkers treatments Parkinson's disease (PD) risk factors bibliometric analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fnagi.2025.1640566/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Plasma extracellular vesicle neurofilament light chain as the biomarkers of the progression of Parkinson’s disease
by: Chien-Tai Hong, et al.
Published: (2024-12-01)

Potential cerebrospinal fluid metabolomic biomarkers and early prediction model for Parkinson’s disease
by: Yifan Zhang, et al.
Published: (2025-05-01)

Exploring the landscape of Parkinson’s disease transcriptomics: a quantitative review of research progress and future directions
by: Yiran Wang, et al.
Published: (2025-05-01)

Advancements in Parkinson’s Disease Diagnosis: A Comprehensive Survey on Biomarker Integration and Machine Learning
by: Ruchira Pratihar, et al.
Published: (2024-11-01)

Depression in Parkinson’s Disease – Profile and Assessment
by: Desislava Marinova, et al.
Published: (2023-12-01)

TREM 2 in Parkinson’s Disease: A Promising Candidate Gene for Disease Susceptibility and Progression
by: Paolo Alonge, et al.
Published: (2025-04-01)

An integrated bioinformatics and machine learning approach to identifying biomarkers connecting parkinson’s disease with purine metabolism-related genes
by: Yao Wang, et al.
Published: (2025-04-01)

Early detection of Parkinson's disease: Retinal functional impairments as potential biomarkers
by: Victoria Soto Linan, et al.
Published: (2025-05-01)

CSF Biomarker‐Based Cognitive Trajectories in Parkinson's Disease‐Subjective Cognitive Decline
by: Jon Rodriguez‐Antiguedad, et al.
Published: (2025-08-01)

Early diagnosis of Parkinson’s disease: biomarker study
by: Jing Li, et al.
Published: (2025-05-01)

Exploring sphingolipid metabolism-related biomarkers for Parkinson’s disease: a transcriptomic analysis
by: Guohong Wang, et al.
Published: (2025-06-01)

Quantifying Lenition as a Diagnostic Marker for Parkinson’s Disease and Atypical Parkinsonism
by: Ratree Wayland, et al.
Published: (2024-11-01)

Small Molecules in Parkinson’s Disease Therapy: From Dopamine Pathways to New Emerging Targets
by: Hwayoung Lee, et al.
Published: (2024-12-01)

Parkinson’s Disease Detection Based on Transfer Learning
by: Mohammad Talal Ghazal
Published: (2024-09-01)

Corrigendum: Parkin characteristics and blood biomarkers of Parkinson's disease in WPBLC study
by: Haijun He, et al.
Published: (2025-05-01)

Role of proinflammatory biomarkers in Parkinson's disease with non-motor symptoms: A systematic review and meta-analysis
by: Setiawan Sulisthio, et al.
Published: (2024-06-01)

Editorial: The neuroscience of Parkinson's disease: exploring causes, symptoms, and potential treatments
by: Jurgen Germann, et al.
Published: (2025-04-01)

A modern view on potential biomarkers of Parkinson’s disease (review)
by: A. V. Demchenko, et al.
Published: (2020-08-01)

Considerations for Advancing Parkinson’s Disease Research in Middle East, North Africa, and South Asia
by: Halder J. Abozait, et al.
Published: (2025-07-01)

Tryptophan metabolism-related gene CYP1B1 serves as a shared biomarker for both Parkinson’s disease and insomnia
by: Xin-Yu Li, et al.
Published: (2025-01-01)

Mass spectrometry‐based proteomics for biomarker discovery in the Drosophila model of Parkinson's disease
by: Mohammad Radid Khan, et al.
Published: (2024-12-01)

Exploring Tau-C, Tau-A, and C1M as biomarkers for Parkinson’s disease
by: Meryem Benmarce, et al.
Published: (2025-04-01)

Glutamate-cysteine ligase as a diagnostic biomarker and therapeutic target in Parkinson's disease: a multi-omics and experimental study
by: Xuzhao Li, et al.
Published: (2025-08-01)

Stressful life events and coping style in Parkinson's disease patients before the initial diagnosis
by: Laura Sophie Neumaier, et al.
Published: (2025-06-01)

The Effects of Pilates in Parkinson’s Disease—A Narrative Review
by: Józef Alfons Opara, et al.
Published: (2025-06-01)

Significance of nicotine and nicotinic acetylcholine receptors in Parkinson’s disease
by: Xia Lin, et al.
Published: (2025-03-01)

THE LEVEL OF Α-SYNUCLEIN IN THE PLASMA AS A BIOMARKER OF PAIN IN PARKINSON'S DISEASE TAKING INTO ACCOUNT THE MOTOR SUBTYPES
by: K.A. Tarianyk
Published: (2024-07-01)

Metabolomic profiling uncovers diagnostic biomarkers and dysregulated pathways in Parkinson’s disease
by: Hongfang Chen, et al.
Published: (2025-06-01)

Screening, identification, and experimental validation of SUMOylation biomarkers in Parkinson’s disease
by: Yifo Wei, et al.
Published: (2025-08-01)

Identifying network state-based Parkinson’s disease subtypes using clustering and support vector machine models
by: Benedictor Alexander Nguchu, et al.
Published: (2025-02-01)

Optimized Time-domain Feature Extraction for Early Onset Diagnosis of Parkinson Disease From EEG Signals
by: Delshad Ghavami, et al.
Published: (2025-07-01)

Parkinson’s Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation
by: Masaru Tanaka
Published: (2025-07-01)

Nonmotor symptoms in Parkinson’s disease patients in South Asia: A systematic review and meta-analysis
by: Prayash Paudel, et al.
Published: (2025-01-01)

The use of an antagonist 5-HT2a/c for depression and motor function in Parkinson' disease Uso de um antagonista 5-HT2a/c na depressão e na função motora de pacientes com doença de Parkinson
by: Antonio Luiz dos Santos Werneck, et al.
Published: (2009-06-01)

Remote clinical decision support tool for Parkinson’s disease assessment using a novel approach that combines AI and clinical knowledge
by: Harel Rom, et al.
Published: (2025-08-01)

TUDCA combined with Syndopa protects the midbrain and gut from MPTP toxicity in a Parkinson’s disease mouse model: Immunohistochemical evidence
by: Mahalakshmi Rajan, et al.
Published: (2025-08-01)

Writing the Future: Artificial Intelligence, Handwriting, and Early Biomarkers for Parkinson’s Disease Diagnosis and Monitoring
by: Giuseppe Marano, et al.
Published: (2025-07-01)

Meta-analysis and in-silico functional characterization of the SNCA variant rs356220 in Parkinson’s disease
by: Shradha Menon, et al.
Published: (2025-07-01)

Substantia nigra and blood gene signatures and biomarkers for Parkinson’s disease from integrated multicenter microarray-based transcriptomic analyses
by: Hui-Hui Fan, et al.
Published: (2025-04-01)

Biosensors for Early Detection of Parkinson’s Disease: Principles, Applications, and Future Prospects
by: Panpan Jiang, et al.
Published: (2025-04-01)